2011 Prostate Cancer Highlights, Prostate Cancer Research Program, Congressionally Directed Medical Research Programs
Resistance to second generation antiandrogens in prostate cancer: pathways and mechanisms
Enzalutamide versus abiraterone as a first-line endocrine therapy for castration-resistant prostate cancer (ENABLE study for PCa): a study protocol for a multicenter randomized phase III trial | BMC Cancer | Full Text
Abiraterone | C24H31NO | CID 132971 - PubChem
Abiraterone Acetate tablets 250mg price in India
Mechanism of Action of Abiraterone Acetate 7 | Download Scientific Diagram
AusPAR Attachment 1: Product Information for Zytiga (abiraterone acetate)
Cancers | Free Full-Text | The Prostate Cancer Therapy Enzalutamide Compared with Abiraterone Acetate/Prednisone Impacts Motivation for Exploration, Spatial Learning and Alters Dopaminergic Transmission in Aged Castrated Mice
Abiraterone Acetate - an overview | ScienceDirect Topics
AUA 2012 - mCRPC in focus: Androgen biosynthesis inhibition and metastatic castration-resistant prostate cancer, clinical insights from the Clinical Industry Theater presentation by Judd Moul, MD
Abiraterone acetate - Wikipedia
How ZYTIGA® Works | ZYTIGA® (abiraterone acetate)
Abiraterone and other novel androgen-directed strategies for the treatment of prostate cancer: a new era of hormonal therapies is born - Michael T. Schweizer, Emmanuel S. Antonarakis, 2012
Optimal sequencing of enzalutamide and abiraterone acetate plus prednisone in metastatic castration-resistant prostate cancer: a multicentre, randomised, open-label, phase 2, crossover trial - The Lancet Oncology
Cardiovascular Effects of Androgen Deprivation Therapy in Prostate Cancer: Contemporary Meta-Analyses | Arteriosclerosis, Thrombosis, and Vascular Biology
CYP17 blockade by abiraterone: further evidence for frequent continued hormone-dependence in castration-resistant prostate cancer | British Journal of Cancer
Mechanism of action of abiraterone and antiandrogens. Abbreviations: A,... | Download Scientific Diagram
Dosage & Monitoring Considerations | ZYTIGA® (abiraterone acetate)
Frontiers | Second-Generation Antiandrogens: From Discovery to Standard of Care in Castration Resistant Prostate Cancer
Abiraterone acetate plus prednisone versus placebo plus prednisone in chemotherapy-naive men with metastatic castration-resistant prostate cancer (COU-AA-302) final overall survival analysis of a randomised, double-blind, placebo-controlled phase 3 ...
pipeline -
Abiraterone acetate in the treatment of prostate cancer - ScienceDirect
The accidental discovery of the world's most expensive prebiotic? | Microbiology Community
Abiraterone acetate in the treatment of prostate cancer - ScienceDirect
Abiraterone: New Drug in the Treatment of Metastatic Castration-resistant Prostate Cancer - The ASCO Post
